ShareValue scores for NUWE: Valuation 66, Quality 38, Growth 60, Health 50.

NUWE
NASDAQ

Nuwellis Inc

$1.63(-4.68%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

7% to 18%
Valuation
66
Fair Value
Price vs Value
Quality
38
Weak
Business Strength
Growth
60
Moderate
Revenue & Earnings
Health
50
Moderate
Financial Stability
Momentum
94
Bullish
Price Trend

Company Details

About

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026